Slideset
View More
In this downloadable slideset, review criteria for initiating HBV therapy, opportunities to broaden candidacy for treatment, and the potential biologic consequences of untreated infection.
Hear expert insights on the evidence for treating patients with immune-tolerant CHB and what ALT threshold should define HBV treatment candidacy in this on-demand audio commentary.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.